Polysaccharide EV Capture
The Polysaccharide EV Capture method

The polysaccharide capture is a patent pending method (WO2014012168) that is used for the isolation and purification of extracellular vesicles (EV). Species of complex sugars are used for the precipitation and capture of EVs using slow and gentle procedures keeping the integrity of the vesicles for subsequent applications. ACRI’s candidate polysaccharides are already FDA approved for multiple formulations, wound healing and internal use, making them ideal for therapeutic purposes in human medicine. Using stem cell-derived EVs or drug-loaded EVs could show promise in the medical field.

The low cost of the molecules makes this method amenable to large scale isolation of EVs for therapeutic purposes. 
VIEW POLYSACCHARIDE PATENT





What are exosomes and EVs?

Exosomes and extracellular vesicles (EVs) are cell-derived nano-sized membrane-encapsulated particles (30-300nm) that act as intermediates in an elaborate communication network, which cells in the body use to deliver complex messages to other cells. EVs can be viewed as nano-cargo transports that circulate in both humans and animals and contain vital information that can inform us in real-time on both normal and disease processes that are occurring within the body. As such, EVs contain a sample of the DNA, RNA, protein and metabolites found within the cells from which they are derived. Since EVs appear in body fluids such as blood and urine, they are also a biomarker source that may be obtained by minimally-invasive methods in order to screen for disease.

Exosomes


For technology information, collaborations or partnerships, please contact: 

Remi Richard
Business Development Agent
This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone : +1 506 869 2048
Fax : +1 506 862 7571

Twitter

Archived Articles

btn campain EN
Atlantic Cancer Research Institute 
Pavillon Hôtel-Dieu
35, Providence Street
Moncton, NB E1C 8X3 Canada

info@canceratl.ca
Tel.: 506-862-7512
Fax.: 506-862-7571

Annual Report 2017 Cover
Our annual report
Download PDF bullet blanc

The Atlantic Cancer Research Institute

 (ACRI) is a non-profit organization founded in late 1998 and housed at the Dr. Georges-L.-Dumont University Hospital Centre in Moncton. Thanks to its unique expertise, ACRI has become a true centre of excellence in cancer research.

Our Partners

logo excipio logo chudumont logo soricimedlogo neplogo ccslogo umonctonlogo unblogo vitalitelogo conceptiaCRS logoNBHRF logoMerck Logo.svg